51183404 Repaglinide

Definition

UNSPSC 51183404

This classification denotes an anti-diabetic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 668Z8C33LU. European Medicines Agency schedules Repaglinide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10280MIG. Repaglinide generally arises in the molecular formula C27H36N2O4. The term REPAGLINIDE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 6, no, 3 1992, list 32.) REPAGLINIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule repaglinide under HS 29333999 and SITC 51574. As of Q4 2014, REPAGLINIDE remains US FDA's Preferred Term for this commodity. Repaglinide bears US NLM identifiers UMLS ID C0246689 and NCI Concept Code C47703. SMILES: O=C(NC(C1C(N2CCCCC2)CCCC1)CC(C)C)CC1CC(OCC)C(CC1)C(=O)O.

Same parent

Under 51183400 · 7

51183401 Aminoguanidine or pimagedine Commodity 51183402 Mitiglinide Commodity 51183403 Nateglinide Commodity 51183404 Repaglinide You are here 51183405 Mitiglinide calcium Commodity 51183406 Mitiglinide calcium dihydrate Commodity 51183407 Mitiglinide calcium hydrate Commodity

Activities that produce or sell this

KBLI · 8

Inherited from family 51180000.

21012 Industri Produk Farmasi untuk Manusia Sub-class 21013 Industri Produk Farmasi untuk Hewan Sub-class 46441 Perdagangan Besar Sediaan Farmasi untuk Manusia Sub-class 46442 Perdagangan Besar Sediaan Farmasi untuk Hewan Sub-class 46902 Perdagangan Besar Berbagai Macam Barang Selain di Grosir/Perkulakan Swalayan Sub-class 47721 Perdagangan Eceran Sediaan Farmasi untuk Manusia di Apotek Sub-class 47722 Perdagangan Eceran Sediaan Farmasi untuk Manusia Selain di Apotek Sub-class 47726 Perdagangan Eceran Obat Farmasi untuk Hewan Sub-class